In some cases, vaccines for COVID-19 can lead to a disease flare in people with cold agglutinin disease (CAD)…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Cold agglutinin disease (CAD) and not the cancer therapy Keytruda (pembrolizumab) was found to be the cause of…
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…
The case of an 80-year-old man with cold agglutinin disease (CAD) who underwent abdominal surgery to remove his gallbladder…
Cold agglutinin disease (CAD) is more frequently diagnosed during winter months at multiple locations across Europe, supporting outdoor temperature…
The case of a man with COVID-19 who temporarily developed elevated levels of cold agglutinins — the self-reactive antibodies…
A type of protein modification called glycosylation is associated with higher levels of disease-causing antibodies in cold agglutinin disease…
The burden of disease among people with primary cold agglutinin disease (CAD) remains high multiple years after diagnosis, illustrating…
Cold agglutinin disease (CAD) disease negatively affects a variety of aspects of daily living, with patients often experiencing…
People with non-Hodgkin’s lymphoma (NHL) — a type of blood cancer — that co-occurs with autoimmune hemolytic anemia…